威訊控股(01087.HK)進一步售出55.35萬股力高股份 總代價約994.6萬港元
格隆匯7月28日丨威訊控股(01087.HK)公吿,自2022年4月1日至2022年4月4日期間,賣方春霖集團有限公司(公司的間接全資附屬公司)開展一系列場內交易,出售合共12.7萬股力高股份(佔力高健康全部已發行股本的約0.064%),平均出售價為每股力高股份約8.48港元,總代價約為107.7萬港元(不包括第一次出售事項引致的交易成本)。
董事會謹此宣佈,於2022年7月27日,賣方通過場內交易,出售55.35萬股力高股份。進一步售出股份共包括55.35萬股力高股份,於公吿日期佔力高健康全部已發行股本的約0.277%。進一步出售事項的每股力高股份的平均售價約17.97港元,為進一步出售事項時的力高股份市價,其總代價約為994.6萬港元(不包括進一步出售事項引致的交易成本)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.